David Pyring

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• AstraZeneca (Sweden)31.1%
• Merck & Co., Inc., Rahway, NJ, USA (United States)10.1%
• Shionogi (Japan)9.4%
• Futaba (Japan)9.4%
• Array BioPharma (United States)6.6%
• Chinese Academy of Sciences5%
• Other28.3%

Fields

• Medicine55.2%
• Computer Science24.1%
• Pharmacology, Toxicology and Pharmaceutics8.6%
• Biochemistry, Genetics and Molecular Biology5.2%
• Chemistry5.2%
• Neuroscience1.7%

Topics

• Computational Drug Discovery Methods24.5%
• Alzheimer's disease research and treatments23.7%
• Cholinesterase and Neurodegenerative Diseases15.1%
• Protein Structure and Dynamics8.6%
• Chemical Synthesis and Analysis4.3%
• Fluorine in Organic Chemistry4.3%
• Other19.4%